FULC Earnings Fulcrum Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.25 | 2026-04-27 | 10-Q |
| FY 2025 | 2025-12-31 | -1.18 | 2026-02-24 | 10-K |
| Q3 2025 | 2025-09-30 | -0.87 | 2025-10-29 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.56 | 2025-07-29 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.28 | 2026-04-27 | 10-Q |
| FY 2025 | 2024-12-31 | -0.16 | 2026-02-24 | 10-K |
| Q3 2025 | 2024-09-30 | 0.11 | 2025-10-29 | 10-Q |
| Q2 2025 | 2024-06-30 | 0.45 | 2025-07-29 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.43 | 2025-05-01 | 10-Q |
| FY 2024 | 2023-12-31 | -1.59 | 2025-02-25 | 10-K |
| Q3 2024 | 2023-09-30 | -1.19 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.80 | 2024-07-31 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.41 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | -2.44 | 2024-02-27 | 10-K |
| Q3 2023 | 2022-09-30 | -1.97 | 2023-11-07 | 10-Q |
| Q1 2023 | 2022-06-30 | -1.47 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.64 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-12-31 | -2.29 | 2023-03-09 | 10-K |
| Q3 2022 | 2021-09-30 | -1.71 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.14 | 2022-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.